MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Study suggests Pfizer-BioNTech COVID-19 vaccine is effective against emerging variants

Study suggests Pfizer-BioNTech COVID-19 vaccine is effective against emerging variants

By

Pfizer-BioNTechA Pfizer-BioNTech preprint published today suggests that their BNT162b2 vaccine will be effective against SARS-CoV2 variants from the U.K. and South Africa, leading to “small differences in viral neutralization” compared with earlier variants.

The U.K variant has been identified in 26 states in the U.S., while the South Africa variant has been found circulating in South Carolina.

The Pfizer and University of Texas Medical Branch scientists conducting the research concluded that modifying the BNT162b2 was unnecessary.

Get the full story from our sister site, Drug Discovery & Development.

More recent news

About Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at [email protected].